|
Delayed
OTC Markets
19:18:02 20/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 0.0300 USD | -3.23% |
|
0.00% | +15.38% |
| 05-18 | Adaptimmune Therapeutics plc Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 11-17 | Adaptimmune Therapeutics plc Announces CEO Changes | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.23% | 0.00% | -7.69% | +11.11% | +15.38% | -40.00% | -93.01% | -99.27% | -99.42% | 8.22M | ||
| +0.03% | -6.23% | +5.44% | +8.77% | +25.95% | +29.74% | +126.49% | +419.71% | +1,666.08% | 1,204B | ||
| +1.66% | -4.78% | +4.91% | +1.77% | +31.48% | +33.99% | +81.50% | +70.38% | +136.60% | 643B | ||
| +1.74% | -2.05% | -0.03% | +10.37% | +26.48% | +25.95% | +108.94% | +149.88% | +378.30% | 501B | ||
| -0.60% | -1.95% | +1.77% | +6.72% | +20.90% | +27.26% | +67.32% | +8.24% | +71.85% | 378B | ||
| +1.24% | -8.79% | -9.12% | -9.54% | +28.04% | +41.91% | +31.25% | +65.08% | +116.32% | 327B | ||
| +0.41% | -4.70% | +1.00% | +1.12% | +16.57% | +27.23% | +51.59% | +67.69% | +80.84% | 285B | ||
| +0.81% | -4.08% | +6.29% | +10.95% | -2.74% | -1.74% | +32.71% | +58.85% | +210.07% | 270B | ||
| +0.34% | -6.08% | -0.36% | +0.84% | +33.62% | +30.14% | +64.82% | +115.73% | +200.48% | 237B | ||
| +0.82% | +0.01% | +7.40% | +17.19% | +36.95% | +34.49% | +121.18% | +140.24% | +124.19% | 207B | ||
| -0.25% | -5.01% | +1.26% | -10.69% | -18.68% | -15.80% | -62.38% | -28.74% | +132.73% | 172B | ||
| -0.02% | -4.47% | -8.34% | -0.68% | +10.84% | +13.11% | -7.94% | -46.09% | -12.58% | 157B | ||
| -0.28% | -3.43% | +1.06% | -3.73% | +14.72% | +23.16% | +45.75% | +186.56% | +484.07% | 132B | ||
| +1.43% | -2.05% | +4.86% | +28.78% | +31.68% | +27.16% | +138.46% | +386.41% | +664.18% | 123B | ||
| +1.33% | -6.79% | -4.15% | -9.70% | +9.60% | +28.69% | +20.90% | +3.65% | +4.21% | 119B | ||
| +1.35% | -3.06% | +15.41% | +9.17% | +2.66% | -0.47% | -0.59% | -4.97% | +12.18% | 110B | ||
| +0.85% | -3.61% | -1.39% | -4.06% | +0.99% | +4.66% | +30.86% | -3.42% | -2.74% | 96.01B | ||
| +0.06% | -3.39% | +14.31% | +11.67% | +19.59% | +25.25% | +15.15% | +43.41% | +127.65% | 92.66B | ||
| -3.04% | -13.56% | -20.24% | +44.83% | +554.77% | +763.56% | +144.54% | -31.69% | - | 80.65B | ||
| -2.16% | -0.55% | +12.24% | +3.25% | -13.76% | -12.89% | +44.99% | +72.88% | +548.24% | 74.78B | ||
| Average | +0.13% | -3.65% | +1.23% | +6.41% | +42.25% | +53.27% | +48.13% | +78.73% | +254.91% | 260B | |
| Weighted average by Cap. | +0.53% | -4.63% | +2.33% | +5.54% | +29.33% | +36.23% | +75.21% | +155.09% | +530.65% |
- Stock Market
- Stocks
- ADAPY Stock
- Sector Adaptimmune Therapeutics plc
Select your edition
All financial news and data tailored to specific country editions
















